LACK OF EVIDENCE OF OCCULT HUMAN-IMMUNODEFICIENCY-VIRUS IN SERONEGATIVE INDIVIDUALS AT VERY HIGH-RISK OF INFECTION

被引:4
|
作者
CROWE, SM
ELBEIK, T
ULRICH, PP
MILLS, J
MOSS, A
机构
[1] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DIV INFECT DIS,SAN FRANCISCO,CA 94110
[2] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT LAB MED,SAN FRANCISCO,CA 94110
[3] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT EPIDEMIOL & BIOSTAT,SAN FRANCISCO,CA 94110
[4] FAIRFIELD HOSP,MACFARLANE BURNET CTR MED RES,MELBOURNE,AUSTRALIA
关键词
SERONEGATIVE; HIGH RISK; HUMAN IMMUNODEFICIENCY VIRUS; NEGATIVE CULTURE; NEGATIVE PCR;
D O I
10.1002/jmv.1890350304
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Reports of human immunodeficiency virus (HIV) infection in seronegative individuals prompted the authors to investigate subjects who are at very high risk of acquisition of HIV in San Francisco. Nine HIV seronegative subjects were evaluated extensively, eight of whom were drawn from a well-characterized cohort of seropositive and seronegative homosexual men who have been followed prospectively since 1983-1984. These men have calculated probabilities of infection based on a fitted model of between 0.22 and 0.94. One additional subject is an intravenous drug user who has shared needles with HIV-infected individuals extensively. Peripheral blood lymphocytes and monocytes were separately cultured from each subject and evidence of HIV infection was sought by a reverse transcriptase assay, enzyme immunoassay, and immunocytofluorographic analysis for HIV antigens, in situ hybridization, RNA slot blot analysis, and polymerase chain reaction amplification of HIV cDNA. Uncultured monocytes and lymphocytes from each donor were also examined by these techniques. Evidence of HIV infection was not found in the peripheral blood mononuclear cells of these high risk individuals.
引用
收藏
页码:160 / 164
页数:5
相关论文
共 50 条
  • [41] THE IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    PANTALEO, G
    GRAZIOSI, C
    FAUCI, AS
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (05): : 327 - 335
  • [42] NEUROSYPHILIS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    WHITEFIELD, SG
    EVERETT, AS
    REIN, MF
    JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (03): : 609 - 609
  • [43] PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    LEVY, JA
    VIRAL ONCOGENESIS AND CELL DIFFERENTIATION: CONTRIBUTIONS OF CHARLOTTE FRIEND, 1989, 567 : 58 - 68
  • [44] IMMUNOPATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    IOACHIM, HL
    CANCER RESEARCH, 1990, 50 (17) : S5612 - S5617
  • [45] THE EPIDEMIOLOGY OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    GLASNER, PD
    KASLOW, RA
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 1990, 58 (01) : 13 - 21
  • [46] PSORIASIS AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    OBUCH, ML
    MAURER, TA
    BECKER, B
    BERGER, TG
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 27 (05) : 667 - 673
  • [48] NEPHROPATHY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    ESFORZADO, N
    FELIZ, T
    ALMIRALL, J
    TORRAS, A
    MIRO, JM
    GATELL, JM
    REVERT, L
    MEDICINA CLINICA, 1992, 98 (20): : 764 - 767
  • [49] TREATMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
    LABROOY, J
    CURRENT OPINION IN NEUROLOGY AND NEUROSURGERY, 1990, 3 (02): : 229 - 233
  • [50] HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION OF THE LIVER
    LAFON, ME
    KIRN, A
    SEMINARS IN LIVER DISEASE, 1992, 12 (02) : 197 - 204